Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study.
China
HPV vaccination uptake
female college student
willingness to receive
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
16 Jan 2020
16 Jan 2020
Historique:
received:
12
12
2019
revised:
30
12
2019
accepted:
14
01
2020
entrez:
23
1
2020
pubmed:
23
1
2020
medline:
23
1
2020
Statut:
epublish
Résumé
This study aimed to determine human papillomavirus (HPV) vaccine uptake and willingness to receive HPV vaccination among female college students, in China, and its associated factors. An online cross-sectional survey of female college students across the eastern, central, and western regions of China was undertaken between April and September 2019. Partial least squares structural equation modeling (PLS-SEM) was used to examine factors associated with the HPV vaccine uptake and willingness to receive the HPV vaccine. Among the total 4220 students who participated in this study, 11.0% reported having been vaccinated against HPV. There are direct effects of indicators of higher socioeconomic status, older age (β = 0.084 and p = 0.006), and geographical region (residing in Eastern China, β = 0.033, and p = 0.024) on HPV vaccine uptake. Higher knowledge (β = 0.062 and p < 0.000) and perceived susceptibility (β = 0.043 and p = 0.002) were also predictors of HPV vaccine uptake. Of those who had not received the HPV vaccine, 53.5% expressed a willingness to do so. Likewise, social economic status indicators were associated with the willingness to receive the HPV vaccine. Total knowledge score (β = 0.138 and Geographical region and socioeconomic disparities in the HPV vaccination uptake rate and willingness to receive the HPV vaccine provide valuable information for public health planning that aims to improve vaccination rates in underserved areas in China. The influence of knowledge and perceptions of HPV vaccination suggests the importance of communication for HPV immunization.
Sections du résumé
BACKGROUND
BACKGROUND
This study aimed to determine human papillomavirus (HPV) vaccine uptake and willingness to receive HPV vaccination among female college students, in China, and its associated factors.
METHODS
METHODS
An online cross-sectional survey of female college students across the eastern, central, and western regions of China was undertaken between April and September 2019. Partial least squares structural equation modeling (PLS-SEM) was used to examine factors associated with the HPV vaccine uptake and willingness to receive the HPV vaccine.
RESULTS
RESULTS
Among the total 4220 students who participated in this study, 11.0% reported having been vaccinated against HPV. There are direct effects of indicators of higher socioeconomic status, older age (β = 0.084 and p = 0.006), and geographical region (residing in Eastern China, β = 0.033, and p = 0.024) on HPV vaccine uptake. Higher knowledge (β = 0.062 and p < 0.000) and perceived susceptibility (β = 0.043 and p = 0.002) were also predictors of HPV vaccine uptake. Of those who had not received the HPV vaccine, 53.5% expressed a willingness to do so. Likewise, social economic status indicators were associated with the willingness to receive the HPV vaccine. Total knowledge score (β = 0.138 and
CONCLUSIONS
CONCLUSIONS
Geographical region and socioeconomic disparities in the HPV vaccination uptake rate and willingness to receive the HPV vaccine provide valuable information for public health planning that aims to improve vaccination rates in underserved areas in China. The influence of knowledge and perceptions of HPV vaccination suggests the importance of communication for HPV immunization.
Identifiants
pubmed: 31963370
pii: vaccines8010031
doi: 10.3390/vaccines8010031
pmc: PMC7157221
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Natural Science Foundation of China
ID : 81660545,81960592
Organisme : National Key R&D Program of China
ID : 2017YFC1310902,2018YFC1315305
Organisme : Ningbo Health Branding Subject Fund
ID : PPXK2018-02
Organisme : Natural Science Foundation of Zhejiang Province
ID : LY17H260002
Organisme : Sanming Project of Medicine in Shenzhen
ID : SZSM201803080
Organisme : Program for innovative Research team(in Science and Technology) in university of Yunnan Province
ID : (2018)134
Déclaration de conflit d'intérêts
Dr. Zimet has served and has received an honorarium from Sanofi Pasteur for his work on the Adolescent Immunization Initiative and travel support from Merck & Co., Inc. to present at an HPV vaccine symposium.
Références
Chin Med J (Engl). 2015 Dec 20;128(24):3298-304
pubmed: 26668143
J Infect. 2018 Jun;76(6):522-528
pubmed: 29477803
Vaccine. 2019 Jun 12;37(27):3617-3624
pubmed: 30122646
PLoS One. 2018 Jun 18;13(6):e0198615
pubmed: 29912883
BMC Public Health. 2012 Nov 13;12:972
pubmed: 23148791
Vaccine. 2015 Jun 4;33(24):2830-41
pubmed: 25770785
BMC Womens Health. 2019 Jul 8;19(1):90
pubmed: 31286939
Ann Behav Med. 2012 Oct;44(2):171-80
pubmed: 22547155
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Vaccine. 2019 Oct 16;37(44):6714-6723
pubmed: 31548016
BMC Public Health. 2019 Feb 11;19(1):178
pubmed: 30744637
Ups J Med Sci. 2016;121(1):45-9
pubmed: 26489857
BMC Womens Health. 2018 Jul 27;18(1):130
pubmed: 30053844
Lancet. 2009 Aug 1;374(9687):358
pubmed: 19647592
Int J Prev Med. 2018 Jun 04;9:49
pubmed: 29963300
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
Cancer Med. 2018 May;7(5):2089-2100
pubmed: 29573569
BMC Public Health. 2019 Aug 30;19(1):1195
pubmed: 31470819
Int J Environ Res Public Health. 2016 May 11;13(5):
pubmed: 27187424
PLoS One. 2017 Mar 3;12(3):e0172906
pubmed: 28257434
Int J Environ Res Public Health. 2018 Apr 04;15(4):
pubmed: 29617313
Nat Biotechnol. 2013 Jul;31(7):590-1
pubmed: 23839139
BJOG. 2014 Oct;121 Suppl 5:35-44
pubmed: 25335839
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):533-540
pubmed: 28196849
Oncologist. 2013;18(10):1101-7
pubmed: 24043599
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Cancer Lett. 2017 Aug 10;401:63-71
pubmed: 28476483
BMC Womens Health. 2018 Aug 2;18(1):134
pubmed: 30071837
BMC Public Health. 2016 Mar 03;16:216
pubmed: 26936076
BMC Public Health. 2019 May 2;19(1):488
pubmed: 31046722
Oncologist. 2015 Jun;20(6):627-34
pubmed: 25956407